Shared roles of immune and stromal cells in the pathogenesis of human bronchiolitis obliterans syndrome
Evidence level: single-cell RNA sequencing study of explanted lungs; abstract-only
Single-cell sequencing of explanted lungs from 4 patients with CLAD-BOS, 3 with chronic graft-versus-host-disease BOS and 3 controls found an expanded CD8 tissue-resident memory T cell population.
As of . Primary source: Publisher record via DOI.
Summary
The study performed single-cell RNA sequencing on explanted human lungs from 4 patients with CLAD-BOS, 3 patients with BOS caused by chronic graft-versus-host disease after stem cell transplant, and 3 deceased controls. In both forms of BOS the authors found an expanded population of CD8 tissue-resident memory T cells that was distinct from other chronic lung diseases. BOS samples also expressed genes linked to macrophage chemotaxis and proliferation, including in non-immune cells, and showed dysfunctional stromal cells with both pro- and anti-fibrotic gene programs. The authors suggest substantial overlap between the two forms of BOS and common pathways for possible treatment. The sample is very small.
Details
- doi
- 10.1172/jci.insight.176596
- pmid
- 40232854
- authors
- Mellors PW, Lange AN, Casino Remondo B, Shestov M, Planer JD, Peterson AR, Ying Y, Zhou S, Christie JD, Diamond JM, Cantu E, Basil MC, Gill S
- journal
- JCI Insight
- year
- 2025
- volume
- 10
- issue
- 10
- articleNumber
- e176596
Sources and links
- Publisher record via DOI (primary)
- PubMed 40232854
Related
Links from this record
- supports: Cytotoxic and senescent T cells
- related to: Innate immune activation
- discusses: Bronchiolitis obliterans syndrome (BOS)
Linked from (derived)
- author affiliation matches this institution (PubMed): Penn Medicine Lung Transplant Program (Penn Transplant Institute)
Known gaps in this record
- full text not read (abstract only)
- funding statement and grant numbers
- author affiliations
- centre or centres not stated in the abstract
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.